journal article·2024-12-18

Erythrocyte-Based Biomimetic MOFs as a Triple Epigenetic Regulator for Enhancing Anti-Leukemia Immunity

Min Ding, Xinlun Dai, Chunfeng Yang, Zhen Zhang, Zhihua Wang, Yiqiao Wang, Yumei Li, Fei Yan

Nano Letters· Volume 24· Issue 50
Publisher page

Abstract

While therapeutic strategies targeting epigenetic dysregulation hold promise for leukemia, epigenetic drugs face several limitations, including low utilization rates, the emergence of resistance, and off-target effects. The hypoxic microenvironment in leukemia further impairs drug sensitivity. Here, we synthesized an MOF-based erythrocyte biomimetic nanoplatform to enhance immune responses against leukemia by targeting three epigenetic modifications. UiO-66-NH 2 was loaded with two epigenetic drugs, along with oxygen-rich erythrocytes (red blood cells, RBCs). MA272@MOF@RBC suppressed hypoxia-induced factor (HIF-1α) and its downstream oncogenes, thereby enhancing the efficacy of the epigenetic drugs. The drugs inhibited the growth of leukemia cells by targeting DNA and histone methylation while enhancing m 6 A-RNA methylation. MA272@MOF@RBC activated cytotoxic and memory T cells by increasing the antigenicity of leukemia cells. MA272@MOF@RBC also demonstrated immunotherapeutic effects on solid tumors. This was the first study to report the synthesis of triple epigenetic regulatory biomimetic MOFs with significant clinical potential for tumor immunotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Epigenetics and DNA Methylation · Immune cells in cancer · RNA modifications and cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pediatric Intensive Care Unit, Children’s Medical Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, China

Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China

State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun, 130012, China

Funding

First Hospital of Jilin University · Jilin Provincial Scientific and Technological Development Program · National Natural Science Foundation of China · State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, Jilin University

References (40)

Show source-provided references
1. 10.1016/S0140-6736(23)00108-310.1016/S0140-6736(23)00108-3 ↗
2. 10.1038/s41568-019-0230-910.1038/s41568-019-0230-9 ↗
3. 10.1038/s41375-022-01619-910.1038/s41375-022-01619-9 ↗
4. 10.1038/s41571-021-00509-w10.1038/s41571-021-00509-w ↗
5. 10.1182/blood-2009-09-24097810.1182/blood-2009-09-240978 ↗
6. 10.1038/leu.2016.34910.1038/leu.2016.349 ↗
7. 10.1038/s41422-018-0097-410.1038/s41422-018-0097-4 ↗
8. 10.1016/j.cell.2017.11.03110.1016/j.cell.2017.11.031 ↗
9. 10.1016/j.ccell.2020.04.01710.1016/j.ccell.2020.04.017 ↗
10. 10.1056/NEJMra180503510.1056/NEJMra1805035 ↗
11. 10.1200/JCO.21.0282310.1200/JCO.21.02823 ↗
12. 10.1016/j.ccell.2018.02.00210.1016/j.ccell.2018.02.002 ↗
13. 10.1093/nar/gku127610.1093/nar/gku1276 ↗
14. 10.1038/ncomms1542410.1038/ncomms15424 ↗
15. 10.1038/s41571-019-0267-410.1038/s41571-019-0267-4 ↗
16. 10.1021/acs.chemrev.3c0006210.1021/acs.chemrev.3c00062 ↗
17. 10.1021/acs.accounts.1c0054410.1021/acs.accounts.1c00544 ↗
18. 10.1016/j.ccell.2022.01.00610.1016/j.ccell.2022.01.006 ↗
19. 10.1021/acsnano.1c0554710.1021/acsnano.1c05547 ↗
20. 10.1016/j.cej.2022.13963510.1016/j.cej.2022.139635 ↗
21. 10.1002/smll.20210655810.1002/smll.202106558 ↗
22. 10.1016/j.biomaterials.2018.03.01310.1016/j.biomaterials.2018.03.013 ↗
23. 10.1038/s41571-022-00699-x10.1038/s41571-022-00699-x ↗
24. 10.1038/s41565-023-01533-w10.1038/s41565-023-01533-w ↗
25. 10.1021/acs.nanolett.3c0177510.1021/acs.nanolett.3c01775 ↗
26. 10.1021/acsnano.0c0533210.1021/acsnano.0c05332 ↗
27. 10.1002/adma.20221089510.1002/adma.202210895 ↗
28. 10.1038/s41568-020-0245-210.1038/s41568-020-0245-2 ↗
29. 10.1038/leu.2015.5610.1038/leu.2015.56 ↗
30. 10.1021/acsnano.2c1196510.1021/acsnano.2c11965 ↗
31. 10.1002/anie.20220383810.1002/anie.202203838 ↗
32. 10.1021/acsnano.0c0999610.1021/acsnano.0c09996 ↗
33. 10.1002/adma.20130063810.1002/adma.201300638 ↗
34. 10.1073/pnas.201359811810.1073/pnas.2013598118 ↗
35. 10.7150/thno.5557410.7150/thno.55574 ↗
36. 10.1021/acsami.2c0997810.1021/acsami.2c09978 ↗
37. 10.1002/hon.283410.1002/hon.2834 ↗
38. 10.1002/adfm.20210719510.1002/adfm.202107195 ↗
39. 10.1038/s41375-021-01432-w10.1038/s41375-021-01432-w ↗
40. 10.1002/hep.3016810.1002/hep.30168 ↗